Long-term efficacy and safety of zoledronic acid in patients with bone metastases from renal cell carcinoma

被引：0
|
作者：
Lipton, A
Seaman, J
Zheng, M
机构：
[1] Milton S Hershey Med Ctr, Hershey, PA USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
BONE | 2004年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S62 / S63
页数：2
相关论文
共 50 条
  • [21] CLINICAL SAFETY AND EFFICACY OF LONG-TERM USE OF ZOLEDRONIC ACID HYDRATE FOR BREAST CANCER BONE METASTASIS
    Osako, Tomofumi
    Nishimura, Reiki
    Nishiyama, Yasuyuki
    Tashima, Rumiko
    Nakano, Masahiro
    Fujisue, Mamiko
    Goto, Yukiko
    Kondo, Genzo
    [J]. BREAST, 2013, 22 : S44 - S45
  • [22] Efficacy of Sunitinib in Patients with Renal Cell Carcinoma with Bone Metastases
    Paule, Bernard
    Brion, Nathalie
    [J]. ANTICANCER RESEARCH, 2010, 30 (12) : 5165 - 5168
  • [23] Long-term bisphosphonate treatment of bone metastases from renal cell carcinomal
    Michaelson, MD
    Rosenthal, DL
    Smith, MR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (20) : 4233 - 4233
  • [24] Study Confirms Long-Term Efficacy and Safety of Zoledronic Acid for Postmenopausal Osteoporosis
    不详
    [J]. JOURNAL OF PHARMACY TECHNOLOGY, 2010, 26 (06) : 376 - 376
  • [25] Study confirms long-term renal safety of annual zoledronic acid infusions
    不详
    [J]. Nature Clinical Practice Nephrology, 2008, 4 (10): : 522 - 522
  • [26] Zoledronic acid reduces long-term risk of skeletal complications in patients with advanced renal cell carcinoma or bladder cancer
    Mulders, Peter F.
    Miller, Kurt
    Tchekmedyian, N. Simon
    [J]. JOURNAL OF UROLOGY, 2007, 177 (04): : 429 - 430
  • [27] Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with renal cell carcinoma
    Omae, Kenji
    Tsujimoto, Yasushi
    Honda, Michitaka
    Kondo, Tsunenori
    Tanabe, Kazunari
    Fukuhara, Shunichi
    Furukawa, Toshiaki
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 : 258 - 258
  • [28] Zoledronic acid (zol) provides long-term palliation of bone pain in breast cancer (bc) patients (pts) with bone metastases
    Lothman, H.
    Heatley, S.
    Lipton, A.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2006, 10 (03) : 225 - 226
  • [29] TREATMENT OF BONE METASTASES FROM HEPATOCELLULAR CARCINOMA WITH ZOLEDRONIC ACID
    Addeo, Raffaele
    Montella, Liliana
    Palmieri, Giovannella
    Caraglia, Michele
    Cennamo, Gregorio
    Guarrasi, Rosario
    Iodice, Patrizia
    Mamone, Rosanna
    Faiola, Vincenzo
    D'Agostino, Alberto
    Capasso, Elena
    Maiorino, Luigi
    Pizza, Carmine
    Montesarchio, Vincenzo
    Del Prete, Salvatore
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [30] RETROSPECTIVE DATABASE ANALYSIS OF ZOLEDRONIC ACID TREATMENT PATTERNS IN PATIENTS WITH RENAL CELL CARCINOMA OR BLADDER CANCER AND BONE METASTASES
    Kaura, S.
    Henk, H. J.
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 64 - 64
12345